The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial
Gespeichert in:
van Santen, D.K., et al., The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial. Addiction, vol. 116, n. 12, 2021, p. 3115-3126.
Ref.
574332
Standort:
SIIS Archivo (R.696)
Palabras clave:
Drogodependencias, Drogas ilegales, Vía intravenosa, Programas de mantenimiento, Intercambio de jeringuillas, Reducción de daños, Tratamiento, Opiáceos, Efectos, Transmisión, Sida, Hepatitis, Riesgo, Factor de protección, Evaluación de servicios, Países Bajos
Drogodependencias, Drogas ilegales, Vía intravenosa, Programas de mantenimiento, Intercambio de jeringuillas, Reducción de daños, Tratamiento, Opiáceos, Efectos, Transmisión, Sida, Hepatitis, Riesgo, Factor de protección, Evaluación de servicios, Países Bajos
Ähnliche Einträge: The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial
- Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials
- EFFECTS OF AMSTERDAM NEEDLE AND SYRINGE EXCHANGE
- HUMAN IMMUNODEFICIENCY VIRUS AND HEPATITIS B VIRUS INFECTIONS IN A NEW YORK CITY ALCOHOLIC POPULATION
- Evidence for the effectiveness of interventions to prevent infections among people who inject drugs: Review of mathematical modelling studies of opioid agonist treatment and needle and syringe programmes for preventing hepatitis C transmission
- PREVENTION OF PERINATALLY TRANSMITED HEPATITIS B INFECTION
- The effect of hepatitis C treatment and human immunodeficiency virus (VIH) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam